0001453687-23-000088.txt : 20231115
0001453687-23-000088.hdr.sgml : 20231115
20231115172614
ACCESSION NUMBER: 0001453687-23-000088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brunn Carsten
CENTRAL INDEX KEY: 0001760229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 231411692
MAIL ADDRESS:
STREET 1: C/O SELECTA BIOSCIENCES, INC.
STREET 2: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090109
4
1
wk-form4_1700087164.xml
FORM 4
X0508
4
2023-11-13
0
0001453687
Cartesian Therapeutics, Inc.
RNAC
0001760229
Brunn Carsten
C/O CARTESIAN THERAPEUTICS, INC.
65 GROVE STREET
WATERTOWN
MA
02472
1
1
0
0
President and CEO
0
Common Stock
2023-11-13
4
D
0
55000
2.06
D
728081
D
Common Stock
2023-11-13
4
D
0
13600
2.06
D
714481
D
Common Stock
2023-11-13
4
D
0
169725
2.06
D
544756
D
Common Stock
2023-11-13
4
D
0
282800
2.06
D
261956
D
Employee Stock Option (right to buy)
6.03
2023-11-13
4
D
0
1000000
D
2028-11-30
Common Stock
1000000
0
D
Employee Stock Option (right to buy)
2.20
2023-11-13
4
D
0
330000
D
2029-02-24
Common Stock
330000
0
D
Employee Stock Option (right to buy)
1.75
2023-11-13
4
D
0
400000
0.31
D
2029-10-06
Common Stock
400000
0
D
Employee Stock Option (right to buy)
2.30
2023-11-13
4
D
0
600000
D
2030-01-01
Common Stock
600000
0
D
Employee Stock Option (right to buy)
2.84
2023-11-13
4
D
0
75000
D
2030-06-30
Common Stock
75000
0
D
Employee Stock Option (right to buy)
2.99
2023-11-13
4
D
0
670000
D
2031-01-03
Common Stock
670000
0
D
Employee Stock Option (right to buy)
4.32
2023-11-13
4
D
0
163000
D
2031-09-23
Common Stock
163000
0
D
Employee Stock Option (right to buy)
3.31
2023-11-13
4
D
0
1056100
D
2032-01-02
Common Stock
1056100
0
D
Employee Stock Option (right to buy)
1.13
2023-11-13
4
D
0
1275000
0.93
D
2033-01-01
Common Stock
1275000
0
D
This unvested restricted stock, which was granted on January 4, 2021, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for $113,300, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
This unvested restricted stock, which was granted on September 24, 2021, was canceled in the Merger, in exchange for $28,016, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
This unvested restricted stock, which was granted on January 3, 2022, was canceled in the Merger, in exchange for $349,633.50, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
This unvested restricted stock, which was granted on January 2, 2023, was canceled in the Merger, in exchange for $582,568, representing $2.06 per share, the Cash-out Amount as applied in the Merger.
This option, which provided for vesting as to 25% of the shares on December 1, 2019 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 50% of the shares on October 7, 2020 and the remaining 50% of the shares on October 7, 2021, was canceled in the Merger, in exchange for a cash payment of $124,000, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 25% of the shares on July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger.
This option, which provided for vesting as to 25% of the shares on January 2, 2024 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger, in exchange for a cash payment of $1,185,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
/s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn
2023-11-15